Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Giroux Richard
-
Form 3 Chardan Healthcare Acqui For: Dec 13 Filed by: Chardan Investments, LLC
-
Form EFFECT Chardan Healthcare Acqui
-
Chardan Healthcare Acquisition Corp. (CHAC) Prices 7M Unit IPO at $10/Unit
-
Chardan Healthcare Acquisition Corp. Announces Pricing of $70 Million Initial Public Offering
-
Form CERT Chardan Healthcare Acqui
-
UPDATE: Chardan Capital Markets Starts Synlogic Inc. (SYBX) at Buy
-
Form 8-A12B Chardan Healthcare Acqui
-
Form S-1/A Chardan Healthcare Acqui
-
DealFlow Announces Agenda for The SPAC Conference 2019
-
DealFlow Announces Agenda for The SPAC Conference 2019
-
Form S-1/A Chardan Healthcare Acqui
-
Moderna (MRNA) IPO Opens 4% Lower
-
Moderna (MRNA) Prices 26.276M Share IPO at $23/Sh
-
Moderna Announces Pricing of Initial Public Offering
-
Form S-1/A Chardan Healthcare Acqui
-
Chardan Capital Markets Starts Arcimoto Inc. (FUV) at Buy
-
Form S-1 Chardan Healthcare Acqui
-
I-AM Capital Acquisition Company Announces Closing of Transaction with SMAAASH Entertainment, a fast-growing global virtual reality gaming and sports entertainment company
-
Alberton Acquisition Corporation To Commence Separate Trading of its Ordinary Shares, Rights and Warrants on November 21, 2018; Underwriter To Exercise Over-allotment Option
-
Chardan Capital Markets Starts LogicBio Therapeutics (LOGC) at Buy
-
uniQure BV (QURE) PT Raised to $70 at Chardan Capital Markets
-
Smith Micro Software (SMSI) Announces $7.5 Million Private Placement Offering of Common Stock, Warrants
-
Smith Micro Announces Above Market $7.5 Million Private Placement Offering of Common Stock and Warrants
-
Tabula Rasa Healthcare (TRHC) PT Raised to $91 at Chardan Capital Markets
-
Tivity Health (TVTY) PT Lowered to $41 at Chardan Capital Markets
-
HMS Holdings (HMSY) PT Raised to $37 at Chardan Capital Markets
-
Benefitfocus (BNFT) PT Raised to $43 at Chardan Capital Markets
-
Chardan Capital Markets Starts 4D Pharma Plc (DDDD:LN) at Buy
-
Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital Markets
-
Odyssey Marine Exploration (OMEX) Announces Proposed $5M Registered Direct Offering of Common Shares & Warrants
-
Odyssey Marine Exploration Announces Above Market $5.0 Million Registered Direct Offering of Common Stock and Warrants
-
Wrap Technologies Completes $13.68M Financing; Management and Existing Shareholders Purchase Over 25%
-
ARYA Sciences Acquisition Corp. to Commence Separate Trading of its Class A Ordinary Shares and Warrants on November 2, 2018
-
ChaSerg Technology Acquisition Corp. Announces Closing of Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering
-
ChaSerg Technology Acquisition Corp. Announces Closing of Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering
-
Alberton Acquisition Corp. (ALAC) Prices 10M Units IPO at $10/Unit
-
Alberton Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
LogicBio Therapeutics Announces Closing of Initial Public Offering
-
Krystal Biotech Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
-
PlacementTracker Publishes Q3 2018 Private Placement Market League Tables
-
Chardan Serves as Lead Manager for LogicBio Therapeutics
-
Chardan Serves as Lead Manager for Krystal Biotech
-
UPDATE: Chardan Capital Markets Starts Seres Therapeutics (MCRB) at Buy
-
Krystal Biotech (KRYS) Prices 3M Share Offering at $20/Sh
-
LogicBio Therapeutics Announces Pricing of Initial Public Offering
-
LogicBio Therapeutics Announces Pricing of Initial Public Offering
-
Krystal Biotech Announces Pricing of $60.0 Million Public Offering of Common Stock
-
Chardan Remains Positive on DMC Global (BOOM)

